Efficacy of Intensification Regimes of Biologic Therapy in Patients With Inflammatory Bowel Disease and Secondary Non-Response: Experience of a Single Referral Centre

被引：0
|
作者：
Lukas, Milan
Duricova, Dana
Bortlik, Martin
Machkova, Nadezda
Komarek, Viktor
Bouzkova, Eva
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S591 / S591
页数：1
相关论文
共 50 条
  • [31] Therapeutic thresholds and mechanisms for primary non-response to infliximab in inflammatory bowel disease
    Buhl, Sine
    Dorn-Rasmussen, Maria
    Brynskov, Jorn
    Ainsworth, Mark A.
    Bendtzen, Klaus
    Klausen, Pia Helene
    Bolstad, Nils
    Warren, David J.
    Steenholdt, Casper
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (08) : 884 - 890
  • [32] Pregnancy, postpartum and health of newborn in patients with inflammatory bowel disease: experience at a single-centre
    Diaz Alcazar, M. D. M.
    Martinez Tirado, P.
    Garcia Robles, A.
    de Mora Figueroa, B. Zuniga
    Roa Colomo, A.
    Ruiz Rodriguez, A. J.
    Benito Palma, S.
    Cardena Perez, C.
    Palacios Perez, A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S528 - S528
  • [33] INFECTIOUS COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE RECIEVING BIOLOGIC THERAPY
    Ochoa, C. D.
    Rajaram, P.
    Tanukonda, S.
    Sadikot, R. T.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2016, 64 (02) : 679 - 680
  • [34] Adenocarcinoma in Crohn's disease: the pathologist's experience in a tertiary referral centre of inflammatory bowel disease
    Malvi, Deborah
    Vasuri, Francesco
    Mattioli, Benedetta
    Gruppioni, Elisa
    Fiorentino, Michelangelo
    Gionchetti, Paolo
    Grigioni, Walter F.
    Poggioli, Gilberto
    D'Errico-Grigioni, Antonia
    PATHOLOGY, 2014, 46 (05) : 439 - 443
  • [35] EFFICACY AND DURABILITY OF BIOLOGIC THERAPY AFTER FAILURE OF INITIAL AND SUBSEQUENT BIOLOGIC AGENTS IN INFLAMMATORY BOWEL DISEASE
    Cusumano, Vivy T.
    Ebriani, Joseph
    Prakash, Preeti
    Dua, Anoushka
    Fansiwala, Kush
    Spartz, Ellen
    Sauk, Jenny S.
    Limketkai, Berkeley N.
    GASTROENTEROLOGY, 2022, 162 (07) : S816 - S816
  • [36] Assessing primary response to biologic therapy in Inflammatory Bowel Disease - 'the when and the how?'
    Moore, A. C.
    Peake, S.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S470 - S470
  • [37] Biologic therapy is safe and effective in inflammatory bowel disease (IBD) patients with previous cancer. Experience of a single tertiary IBD center
    Bar-Yishay, I.
    Ron, Y.
    Santo, E.
    Dotan, I.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S400 - S401
  • [38] WEEK 10 INFLIXIMAB CONCENTRATION IDENTIFIES PATIENTS WITH PARTIAL OR NON-RESPONSE TO INFLIXIMAB AND ALLOWS FOR EARLY OPTIMIZATION OF THERAPY IN INFLAMMATORY BOWEL DISEASE
    Syal, Gaurav
    Salem, Mark
    Ha, Christina
    GASTROENTEROLOGY, 2020, 158 (06) : S954 - S955
  • [39] The role of intestinal ultrasound with colour Doppler in predicting the response to biologic therapy in inflammatory bowel disease patients
    El-Nady, Mohamed Ali
    El-Hefny, Nour Eldeen
    Fathy, Hayam
    Ali, Wageeh
    Ashmawy, Ahmed Mohammed
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2024, 19 (04): : 416 - 422
  • [40] SAFETY AND EFFICACY OF BIOLOGIC THERAPY FOR INFLAMMATORY BOWEL DISEASE IN LIVER TRANSPLANT RECIPIENTS FOR PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER EXPERIENCE
    Mousa, Omar Y.
    Tse, Chung Sang
    Sanchez, William
    Keaveny, Andrew Paul
    Kamath, Patrick S.
    Harnois, Denise M.
    Carey, Elizabeth J.
    Picco, Michael F.
    Loftus, Edward V.
    Leighton, Jonathan A.
    Lazaridis, Konstantinos N.
    Watt, Kymberly
    Eaton, John E.
    HEPATOLOGY, 2019, 70 : 702A - 703A
12345